GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $203,000 | -2.4% | 4,672 | -2.2% | 0.07% | -14.9% |
| Q1 2022 | $208,000 | -11.5% | 4,775 | -10.6% | 0.09% | -6.5% |
| Q4 2021 | $235,000 | +6.3% | 5,340 | -7.5% | 0.09% | -2.1% |
| Q3 2021 | $221,000 | -3.9% | 5,772 | +0.1% | 0.10% | -24.6% |
| Q2 2021 | $230,000 | +12.2% | 5,766 | +0.6% | 0.13% | +5.9% |
| Q1 2021 | $205,000 | -21.8% | 5,734 | -19.4% | 0.12% | -28.3% |
| Q4 2020 | $262,000 | -47.6% | 7,110 | -46.5% | 0.17% | -48.3% |
| Q3 2020 | $500,000 | -13.3% | 13,288 | -6.1% | 0.32% | -32.7% |
| Q2 2020 | $577,000 | -7.2% | 14,157 | -13.7% | 0.48% | -21.5% |
| Q1 2020 | $622,000 | -26.8% | 16,403 | -9.4% | 0.61% | +3.4% |
| Q4 2019 | $850,000 | +0.2% | 18,097 | -8.9% | 0.59% | -16.0% |
| Q3 2019 | $848,000 | +3.8% | 19,859 | -1.5% | 0.70% | -2.1% |
| Q2 2019 | $817,000 | -4.0% | 20,161 | -1.0% | 0.72% | -4.5% |
| Q1 2019 | $851,000 | – | 20,374 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |